Collen Lancet: 34L: 34-36(1993). |
Marder N. Eng. J. Med. 318: 1512-1520 (1988). |
Mann et al. in Hemostails & Thrombosis, Coleman Ed. Lippencott Phila PA pp. 112-125 1987. |
Harris, Tibtech 11:42-45 (1993). |
Kavanaugh et al. Arthritis & Rheumatism 37:992-999 (1994). |
Coller et al. Thrombosis & Hemostasis 74(1) 302-308 (1995). |
The Epics Investigators N. Eng. J. Med. 330:956-961 (1994). |
Aihara, M. et al., Factor XIII is Not Involved in Human Platelet-Collagen Interaction, Tohoku J. Exp. Med. 159(1):37-44 (Sep. 1989). |
Baja, P.S. et al., Experimental and Theoretical Evidence Supporting the Role of Gly.sup.363 in Blood Coagulation Factor IXa (Gly.sup.193 in Chymotrypsin) for Proper Activation of the Proenzyme, J. Biol. Chemistry 265(5):2956-2961 (Feb. 15, 1990). |
Birkedal-Hansen, B. et al., Monoclonal Antibodies to Human Fibroblast Procollagenase. Inhibition of Enzymatic Activity, Affinity Purification of the Enzyme, and Evidence for Clustering of Epitopes in the NH.sub.2 -Terminal End of the Acitvated Enzyme, Biochemistry 27:6751-6758 (1988). |
Board, P.G. et al., Expression of Functional Coagulation Factor XIII In Escherichia coli, Thrombosis and Haemostasis 63(2):235-240 (Apr. 12, 1990). |
Bohn, H., Isolierung und Charakterisireung des fibrinstabilisierenden Faktors aus menschlichen Thrombozyten, Thromb. Diath. Haemorrh. (Germany, West) 23:(3):455-468 (Jun. 30, 1970). |
Colasanti, G. et al., deposition of fibrin-stabilizing factor (F XIII A and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy, Clin. Nephrol. 28(1):28-34 (1987). |
Coller, B.S., Platelets and Thrombolytic Therapy, New England Journal of Medicine 322(1):33-42 (Jan. 4, 1990). |
Davis III, A.E., C1 Inhibitor (C1 INH): Genes, Biosynthesis, and Biology, Behring Inst. Mitt. 84:142-150 (1989). |
deFouw, N.J. et al., Activated Protein C Increases Fibrin Clot Lysis by Neutralization of Plasminogen Activator Inhibitor--No Evidence for a Cofactor Role of Protein S, Thromb. Haemost. 60(2):328-333 (Oct. 31, 1988). |
Degen, S.J.F. et al., Characterization of the Complimentary Deoxyribonucleic Acid and Gene Coding for Human Prothrombin, Biochemistry 22:2087 (1985). |
Doyle, P.M. et al., Peptides incorporating electrophilic glutamine analogues as potential transglutaminase inhibitors, Biochemical Society Transaction 18:1318-1320 (1990). |
Elms, M.J. et al., Rapid Detection of Cross-Linked Fibrin Degradation Products in Plasma Using Monoclonal Antibody-Coated Latex Particles, Am. J. Clin. Pathol. 85(3):360-364 (mar. 1986). |
Foster, D.C. et al., The nucleotide sequence of the gene for human protein C, Proc. Natl. Acad. Sci. USA 82:4673 (1985). |
Freifelder, D., in Molecular Biology; A Comprehensive Introduction to Prokaryotes and Eukaryotes, Jones and Bartlett Inc., pp. 478-480 (1983). |
Gaffney, P.J. et al., Fibrin Crosslinks And Lysis Rates, Thrombosis Research 14:85-94 (1979). |
Gershenfeld, H.K. et al., Cloning of a cDNA for a T Cell-Specific Serine Protease from a Cytotoxic T Lymphocyte, Science 232:854-858 (May 16, 1986). |
Gogstad, G.O. et al., Platelet factor XIII is an active enzyme after solubilization and crossed immunoelectrophoresis, Thrombosis Research 29(2):237-241 (Jan. 15, 1983). |
Grundmann, U. et al., Characterization of cDNA coding for juman factor XIIIa, Proc. Natl. Acad. Sci. USA 83:8024-8028 (Nov. 1986). |
Hada, M. et al., Covalent crosslinking of von Willebrand Factor to Fibrin, Blood 68(1):95-101 (Jul. 1986). |
Harlow et al., Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, pp. 72-77. 92-97, 128-135, 141-137 (1988). |
Henderson, K.W. et al., The Mechanism of Enhanced Streptokinase-Induced Clot Lysis following In-vitro Factor-XIII Inactivation, Brit. J. Haematol. 17:445-453 (1969). |
Hendriksson, P. et al., Identification of Intracellular Factor XIII in Human Monocytes and Macrophages, J. Clin. Invest. 76(2):528-534 (Aug. 1985). |
Ichinose, A., et al., Amino Acid Sequence of the a Subunit of Human Factor XIII, Biochem. 25(22):6900-6906 (Nov. 4, 1986). |
Ikematsu et al., Immunochemical studies of Human factor XIII, J. Lab. Clin. Med. 97(5):662-671 (May 1981). |
Jansen, J.W.C.M. et al., Influence of Factor XIIIa Activity on Human Whole Blood Clot Lysis In Vitro, Thrombosis and Haemostasis 57(2):171-175 (Apr. 7, 1987). |
Kelly, R.B. Pathways of Protein Secretion in Eukaryotes, Science 230:25-32 (Oct. 4, 1985). |
Kiesselbach, T.H. et al., Demonstration Of Factor XIII In Human Megakaryocytes By A Fluorescent Antibody Technique, Ann. N.Y. Acad. Sci. 201:318-328 (1972). |
Kirchheimer, J.C. et al., Matrix-Bound Plasminogen Activator Inhibitor Type 1 Inhibits The Invasion of Human Monocytes Into Interstitial Tissue, J. Immunol. 145(5):1518-1522 (Sep. 1, 1990). |
Lerner, R.A.,, Tapping the immunological repertoire to produce antibodies of predetermined specificity, Nature 299:592-596 (Oct. 14, 1982). |
Lopaciuk, S. et al. Differences between Type I Autoimmune Inhibitors of Fibrin Stabilization in Two Patients with Severe Hemmorhagic Disorder, J. Clin. Invest. 61:1196-1203 (1978). |
Lorand et al., Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system, Proc. Natl. Acad. Sci. USA 85:232-236 (Jan. 1988). |
Lukacova, D. et al., Functional Characteristics Of A Monoclonal Antibody Directed To The Thrombin Activation Site Of Faxtor XIII, FASEB J. 5(4):A515 (1991). |
Lukacova, D. et al., Inhibition of Factor XIII Activation by an Anti-Peptide Monoclonal Antibody, Biochem. 30:10164-10170 (1991). |
McDonagh, J. et al., Alternative Pathways for the Activation of Factor XIII, Br. J. Haematol. 30:465-477 (1975). |
McDonagh, J. et al., Site Of Synthesis Of Plasma And Platelet Factor XIII, Ann. N.Y. Acad. Sci. 202:31-40 919720. |
McDonagh, J., Structure and Function of Factor XIII, in Hemostasis & Thrombosis, 2nd Edition. |
McMullen, B.A. et al., Complete Amino Acid sequence of the Light Chain of Himan Blood Coagulation Factor X: Evidence for Identification of Residue 63 as .beta.-Hydroxyaspartic Acid, Biochemistry 22:2875-2884 (1983). |
Muszbek, L. et al., Factor XIII Of Blood Coagulation In Human Monocytes, Thromb, Res. 37(3):401-410 (Feb. 1, 1985). |
Human, R.L. et al., Immunological Studies of Proteins Associated with the Subcellular Fractions of Thrombasthenic an Afibrinogenaemic Platelets, Brit. J. Haemat. 15(2):181-189 (Aug. 1968). |
Neurath, H., Evolution of Proteolytic Enzymes, Science 224:350-357 (Apr. 27, 1984). |
Nilsson, J.L.F. et al., Fibrin-Stabilizing Factor Inhibitors, Annals of the New York Academy of Sciences 202:286-296 (1972). |
Panis, R. et al., Risk of Hepatitis in Fibrin Adhesion, Laryng. Rhinol. (Stuttgart) 60(7):367-368 (Jul. 1981). |
Pincus, S.E. et al., in Inouye, M. et al., Molecular Biology of RNA, pp. 175-180 (1987). |
Procyk, R. et al., Factor XII-induced crosslinking in solutions of fibrinogen and fibronectin, Biochim. Biophys. Acta 967(2):304-313 (Nov. 17, 1988). |
Reed, G.L. et al., Fibrin-fibrin and .alpha.2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis, Trans. Assoc. Am. Physicians 104:21-28 (1991). |
Rinderknecht, H., et al., A possible zymogen self-destrcut mechanism preventing pancreatic autodigestion, Int. J. Pancreatol. 3:33-44 (1988). |
Schmaier A.H. et al., Determination of the Bifunctional Properties of High Molecular Weight Kininogen by Studies with Monoclonal Antibodies Directed to Each of Its Chains, J. Biol. Chem. 262(3):1405-1411 (Jan. 25, 1987). |
Scott, C.F. et al., A New Assay For High Molecular Weight Kininogen In Human Plasma Using A Chromogenic Substrate, Thrombosis Research 48:685-700 (1987). |
Scott, C.F. et al., Inactivation of Factor XIa by Plasma Protease Inhibitors, J. Clin. Invest. 69:844-852 (Apr. 1982). |
Selmayr, E. et al., Crosslinking Of Soluble Fibrin And Fibrinogen, Thrombosis Research 39(4):467-474 (Aug. 15, 1985). |
Shebuski, R.J. et al., Acceleration of tPA0-induced Thrombolysis by an Inhibitor of Factor XIIIa in a Canine Model of Coronary Arterial Thrombosis, Circulation 80(Suppl):II-217, Abstract No. 0866 (1989). |
Sixma, J.J. et al., Immunocytochemical Localization of Albumin and Factor XIII in Thin Cryo Sections of Human Blood Platelets, Thrombosis and Haemostasis 51(3):388-391 (Jul. 29, 1984). |
Takahashi, N. et al., Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta, Proc. Natl. Acad. Sci. USA 86:8019-8023 (1986). |
Vehar, G.A. et al., Structure of human factor VIII, Nature 312:337-342 (1984). |
Wayland, W. et al., Should an injured spleen be preserved?, Zent.bl. Chir. 111(5):241-251 (1986). |
Yoshitake, S. et al., Nucleotide Sequence of the Gene for Human Factor IX (Antihemophillic Factor B), Biochemistry 24:3736-3750 (1985). |